![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
499kB |
| Item Type: | Article |
|---|---|
| Title: | The role and uses of antibodies in COVID-19 infections: a living review |
| Creators Name: | Scourfield, D.C., Reed, S.G., Quastel, M., Alderson, J., Bart, V.M.T., Teijeira Crespo, A., Jones, R., Pring, E., Richter, F.C. and Burnell, S.E.A. |
| Abstract: | Coronavirus disease 2019 has generated a rapidly evolving field of research, with the global scientific community striving for solutions to the current pandemic. Characterizing humoral responses towards SARS-CoV-2, as well as closely related strains, will help determine whether antibodies are central to infection control, and aid the design of therapeutics and vaccine candidates. This review outlines the major aspects of SARS-CoV-2-specific antibody research to date, with a focus on the various prophylactic and therapeutic uses of antibodies to alleviate disease in addition to the potential of cross-reactive therapies and the implications of long-term immunity. |
| Keywords: | Antibodies, COVID-19, SARS-CoV-2, Convalescent Plasma, Nanobodies, Vaccines, Long-Term Immunity |
| Source: | Oxford Open Immunology |
| ISSN: | 2633-6960 |
| Publisher: | Oxford University Press |
| Volume: | 2 |
| Number: | 1 |
| Page Range: | iqab003 |
| Date: | 28 January 2021 |
| Additional Information: | Anna Katharina Simon and Quentin Sattentau are members of the Oxford-Cardiff COVID-19 Literature Consortium. |
| Official Publication: | https://doi.org/10.1093/oxfimm/iqab003 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
